Avatrombopag Maleate News
Avatrombopag Maleate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Avatrombopag Maleate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure. Doptelet is indicated for the...
- Evidence level: L5
- Predicted indications (20):
- marcothrombocytopenia with mitral valve insufficiency (100.0%)
- hereditary thrombocytopenia with normal platelets (100.0%)
- transient neonatal thrombocytopenia (100.0%)
- dense granule disease (100.0%)
- thrombocytopenia (100.0%)
- amyotrophic lateral sclerosis (100.0%)
- bilateral parasagittal parieto-occipital polymicrogyria (100.0%)
- lower motor neuron syndrome with late-adult onset (100.0%)
- amyotrophic lateral sclerosis, susceptibility to (100.0%)
- Mills syndrome (100.0%)
- monomelic amyotrophy (100.0%)
- axial spondylometaphyseal dysplasia (100.0%)
- amyotrohpic lateral sclerosis type 22 (100.0%)
- autosomal dominant mitochondrial myopathy with exercise intolerance (100.0%)
- trichomegaly-retina pigmentary degeneration-dwarfism syndrome (100.0%)
- lethal arthrogryposis-anterior horn cell disease syndrome (100.0%)
- platelet storage pool deficiency (100.0%)
- neuronopathy, distal hereditary motor (99.4%)
- melanoma (98.5%)
- CMM7 (98.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.